Clinical Trial

Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology

Study acronym: FERT-ISSUES
Recruiting
View on ClinicalTrials.gov →
Summary
Cancer treatments, despite their increasing effectiveness, carry a significant risk of gamete toxicity. Women of reproductive age are commonly offered fertility preservation (FP) before starting their treatment. However, few studies have analyzed the long-term reproductive outcomes of these interventions, nor how patients ultimately use or do not use the FP options once in remission. This project aims to better understand the effectiveness, utilization, and psychological impacts of these strategies. This work is part of an effort to understand and evaluate fertility preservation practices implemented for women of reproductive age undergoing cancer treatment at the Amiens-Picardie University Hospital (CHU). Its objective is to document patient pathways, clinical decisions, techniques employed, and reproductive outcomes observed after remission, in order to identify potential areas for improvement in the support and follow-up of these patients, thereby enhancing the overall quality and coordination of care. This work is conducted alongside the development of a fertility observatory at the Department of Medicine and Reproductive Biology, CHU Amiens-Picardie.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-16; most recent amendment 2026-01-15.
Status change: Not Yet Recruiting → Recruiting 2026-01-15
Trial Details
NCT Number NCT07312058
Lead Sponsor Centre Hospitalier Universitaire, Amiens
Conditions Fertility Preservation, Cancer Remission, Reproductive Outcomes, Reproductive Health, Oncology, Fertility Counseling, Assisted Reproductive Technology, Psychological Impact +5 more
Enrollment 102 participants
Start Date 2025-12-17
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-16